Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 94%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
22,467
Total Claims
$2.8M
Drug Cost
397
Beneficiaries
$7,132
Cost/Patient
Risk Score Breakdown 30/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+13%
Opioid rate vs peers
2.5% vs 2.2% avg
+405%
Cost per patient vs peers
$7,132 vs $1,411 avg
+73%
Brand preference vs peers
18.4% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.5%
Opioid Rate
568
Opioid Claims
$13K
Opioid Cost
10.9%
Long-Acting Rate
Brand vs Generic
Brand: 4,105 claims · $2.3M
Generic: 18,208 claims · $537K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Valbenazine Tosylate | 107 | $467K |
| Pimavanserin Tartrate | 99 | $234K |
| Paliperidone Palmitate | 83 | $230K |
| Apixaban | 704 | $202K |
| Empagliflozin | 328 | $98K |
| Fluticasone/Umeclidin/Vilanter | 153 | $94K |
| Dulaglutide | 112 | $78K |
| Abatacept | 13 | $74K |
| Dextromethorphan Hbr/Quinidine | 78 | $58K |
| Liraglutide | 50 | $44K |
| Bictegrav/Emtricit/Tenofov Ala | 11 | $42K |
| Semaglutide | 39 | $39K |
| Divalproex Sodium | 475 | $38K |
| Rivaroxaban | 138 | $36K |
| Linaclotide | 65 | $36K |
Prescribing Profile
Patient Profile
74
Avg Age
52%
Female
2.60
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About